These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
449 related articles for article (PubMed ID: 11427455)
1. Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with tacrolimus in kidney transplantation. Mourad M; Malaise J; Chaib Eddour D; De Meyer M; König J; Schepers R; Squifflet JP; Wallemacq P Clin Chem; 2001; 47(7):1241-8. PubMed ID: 11427455 [TBL] [Abstract][Full Text] [Related]
2. Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil. Mourad M; Malaise J; Chaib Eddour D; De Meyer M; König J; Schepers R; Squifflet JP; Wallemacq P Clin Chem; 2001 Jan; 47(1):88-94. PubMed ID: 11148182 [TBL] [Abstract][Full Text] [Related]
3. Long-term changes in mycophenolic acid exposure in combination with tacrolimus and corticosteroids are dose dependent and not reflected by trough plasma concentration: a prospective study in 100 de novo renal allograft recipients. Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y J Clin Pharmacol; 2003 Aug; 43(8):866-80. PubMed ID: 12953344 [TBL] [Abstract][Full Text] [Related]
4. Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings. Zucker K; Rosen A; Tsaroucha A; de Faria L; Roth D; Ciancio G; Esquenazi V; Burke G; Tzakis A; Miller J Transpl Immunol; 1997 Sep; 5(3):225-32. PubMed ID: 9402690 [TBL] [Abstract][Full Text] [Related]
5. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens. Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172 [TBL] [Abstract][Full Text] [Related]
6. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes. Budde K; Glander P; Krämer BK; Fischer W; Hoffmann U; Bauer S; Grohmann J; Neumayer HH; Arns W Transplantation; 2007 Feb; 83(4):417-24. PubMed ID: 17318074 [TBL] [Abstract][Full Text] [Related]
7. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant. Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117 [TBL] [Abstract][Full Text] [Related]
8. An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients. Bhatia M; Militano O; Jin Z; Figurski M; Shaw L; Moore V; Morris E; Tallamy B; van deVen C; Ayello J; Baxter-Lowe L; Satwani P; George D; Bradley MB; Garvin J; Cairo MS Biol Blood Marrow Transplant; 2010 Mar; 16(3):333-43. PubMed ID: 19835971 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients. Nashan B; Saliba F; Durand F; Barcéna R; Herrero JI; Mentha G; Neuhaus P; Bowles M; Patch D; Bernardos A; Klempnauer J; Bouw R; Ives J; Mamelok R; McKay D; Truman M; Marotta P Liver Transpl; 2009 Feb; 15(2):136-47. PubMed ID: 19177449 [TBL] [Abstract][Full Text] [Related]
11. Age-dependency of mycophenolate mofetil dosing in combination with tacrolimus after pediatric renal transplantation. Filler G; Foster J; Berard R; Mai I; Lepage N Transplant Proc; 2004 Jun; 36(5):1327-31. PubMed ID: 15251324 [TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy. Grinyó JM; Ekberg H; Mamelok RD; Oppenheimer F; Sánchez-Plumed J; Gentil MA; Hernandez D; Kuypers DR; Brunet M Nephrol Dial Transplant; 2009 Jul; 24(7):2269-76. PubMed ID: 19357111 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine. Lobritto SJ; Rosenthal P; Bouw R; Leung M; Snell P; Mamelok RD Liver Transpl; 2007 Nov; 13(11):1570-5. PubMed ID: 17969194 [TBL] [Abstract][Full Text] [Related]
14. Limits to intensified mycophenolate mofetil dosing in kidney transplantation. Kiberd BA; Lawen J; Daley C Ther Drug Monit; 2012 Dec; 34(6):736-8. PubMed ID: 23007746 [TBL] [Abstract][Full Text] [Related]
15. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation. Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819 [TBL] [Abstract][Full Text] [Related]
16. Optimization of the dosing regimen of mycophenolate mofetil in pediatric liver transplant recipients. Barau C; Barrail-Tran A; Hemerziu B; Habes D; Taburet AM; Debray D; Furlan V Liver Transpl; 2011 Oct; 17(10):1152-8. PubMed ID: 21695772 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of mycophenolate mofetil are influenced by concomitant immunosuppression. Filler G; Zimmering M; Mai I Pediatr Nephrol; 2000 Feb; 14(2):100-4. PubMed ID: 10684356 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil. Beckebaum S; Armstrong VW; Cicinnati VR; Streit F; Klein CG; Gerken G; Paul A; Oellerich M Ther Drug Monit; 2009 Apr; 31(2):205-10. PubMed ID: 19307937 [TBL] [Abstract][Full Text] [Related]
19. Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetil. Kuypers DR; Vanrenterghem Y; Squifflet JP; Mourad M; Abramowicz D; Oellerich M; Armstrong V; Shipkova M; Daems J Ther Drug Monit; 2003 Oct; 25(5):609-22. PubMed ID: 14508385 [TBL] [Abstract][Full Text] [Related]
20. The CLEAR study: a 5-day, 3-g loading dose of mycophenolate mofetil versus standard 2-g dosing in renal transplantation. Gourishankar S; Houde I; Keown PA; Landsberg D; Cardella CJ; Barama AA; Dandavino R; Shoker A; Pirc L; Wrobel MM; Kiberd BA Clin J Am Soc Nephrol; 2010 Jul; 5(7):1282-9. PubMed ID: 20498245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]